These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats. Liu JG; Zhao HJ; Liu YJ; Liu YW; Wang XL J Trace Elem Med Biol; 2012 Oct; 26(4):255-61. PubMed ID: 22425635 [TBL] [Abstract][Full Text] [Related]
3. Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study. Aglan HA; Ahmed HH; El-Toumy SA; Mahmoud NS Tumour Biol; 2017 Jun; 39(6):1010428317699127. PubMed ID: 28618930 [TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway. Hassoun SM; Abdel-Rahman N; Eladl EI; El-Shishtawy MM Tumour Biol; 2017 Jun; 39(6):1010428317707376. PubMed ID: 28651490 [TBL] [Abstract][Full Text] [Related]
5. Effects of VEGF/VEGFR/K-ras signaling pathways on miRNA21 levels in hepatocellular carcinoma tissues in rats. Gao JZ; Wang YL; Li J; Wei LX Genet Mol Res; 2015 Jan; 14(1):671-9. PubMed ID: 25730004 [TBL] [Abstract][Full Text] [Related]
6. Mulberry fruit polysaccharides alleviate diethylnitrosamine/phenobarbital-induced hepatocarcinogenesis in vivo: the roles of cell apoptosis and inflammation. Li S; Li Y; Sun H; Jiang Y; Pan K; Su Y; Bu N Bioengineered; 2021 Dec; 12(2):11599-11611. PubMed ID: 34866538 [TBL] [Abstract][Full Text] [Related]
7. Gallium nanoparticles along with low-dose gamma radiation modulate TGF-β/MMP-9 expression in hepatocellular carcinogenesis in rats. Moawed FS; El-Sonbaty SM; Mansour SZ Tumour Biol; 2019 Mar; 41(3):1010428319834856. PubMed ID: 30859905 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the antitumor activity of platinum nanoparticles in the treatment of hepatocellular carcinoma induced in rats. Medhat A; Mansour S; El-Sonbaty S; Kandil E; Mahmoud M Tumour Biol; 2017 Jul; 39(7):1010428317717259. PubMed ID: 28720064 [TBL] [Abstract][Full Text] [Related]
9. Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice. Nasr M; Selima E; Hamed O; Kazem A Eur J Pharmacol; 2014 Jan; 723():267-75. PubMed ID: 24291100 [TBL] [Abstract][Full Text] [Related]
10. Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice. He Q; Wang F; Honda T; Lindquist DM; Dillman JR; Timchenko NA; Redington AN Tumour Biol; 2017 Oct; 39(10):1010428317737729. PubMed ID: 29072132 [TBL] [Abstract][Full Text] [Related]
11. Possible role of selective, irreversible, proteasome inhibitor (carfilzomib) in the treatment of rat hepatocellular carcinoma. Mansour MA; Aljoufi MA; Al-Hosaini K; Al-Rikabi AC; Nagi MN Chem Biol Interact; 2014 May; 215():17-24. PubMed ID: 24632418 [TBL] [Abstract][Full Text] [Related]
12. Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice. Abo Mansour HE; El-Batsh MM; Badawy NS; Mehanna ET; Mesbah NM; Abo-Elmatty DM Hum Exp Toxicol; 2020 Nov; 39(11):1528-1544. PubMed ID: 32519553 [TBL] [Abstract][Full Text] [Related]
13. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis. Bishayee A; Thoppil RJ; Darvesh AS; Ohanyan V; Meszaros JG; Bhatia D J Nutr Biochem; 2013 Jan; 24(1):178-87. PubMed ID: 22841394 [TBL] [Abstract][Full Text] [Related]
14. Potential chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis in rats: myrrh (Commiphora molmol) vs. turmeric (Curcuma longa). El-Shahat M; El-Abd S; Alkafafy M; El-Khatib G Acta Histochem; 2012 Sep; 114(5):421-8. PubMed ID: 21871653 [TBL] [Abstract][Full Text] [Related]
15. Involvement of NF-κB/PI3K/AKT signaling pathway in the protective effect of prunetin against a diethylnitrosamine induced hepatocellular carcinogenesis in rats. Li G; Qi L; Chen H; Tian G J Biochem Mol Toxicol; 2022 May; 36(5):e23016. PubMed ID: 35239232 [TBL] [Abstract][Full Text] [Related]
16. Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway. Verma A; Singh D; Anwar F; Bhatt PC; Al-Abbasi F; Kumar V Inflammopharmacology; 2018 Feb; 26(1):133-146. PubMed ID: 28608141 [TBL] [Abstract][Full Text] [Related]
17. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro. Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of Diethylnitrosamine-Initiated and Phenobarbital-Promoted Hepatocarcinogenesis in Rats by Sulfated Polysaccharides and Aqueous Extract of Ulva lactuca. Hussein UK; Mahmoud HM; Farrag AG; Bishayee A Integr Cancer Ther; 2015 Nov; 14(6):525-45. PubMed ID: 26130745 [TBL] [Abstract][Full Text] [Related]
19. Anticancer effect of propranolol on diethylnitrosamine-induced hepatocellular carcinoma rat model. Tamim YM; Nagy AA; Abdellah AM; Osman AH; Ismail AFM Fundam Clin Pharmacol; 2024 Aug; 38(4):742-757. PubMed ID: 38325396 [TBL] [Abstract][Full Text] [Related]
20. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling. Hu X; Rui W; Wu C; He S; Jiang J; Zhang X; Yang Y J Gastroenterol Hepatol; 2014 Jun; 29(6):1284-91. PubMed ID: 24329763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]